WHO ICTRP trial
The clinical efficacy of Jinghua Weikang as an alternative to bismuth agents in…
ITMCTR2026000076 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2026000076 |
|---|---|
| Public title | The clinical efficacy of Jinghua Weikang as an alternative to bismuth agents in the treatment of gastric ulcers with Helicobacter pylori (Hp) infection and its impact on inflammatory factors. |
| Scientific title | Correlation Between Helicobacter pylori and Metabolic Dysfunction-Associated Steatohepatitis (MASLD) and Diagnostic Value of Cytokeratin 18 for MASLD |
| Primary sponsor | Hainan Medical University First Affiliated Hospital |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Others |
| Countries | China |
| Conditions | Gastric ulcer |
| Interventions | Control Group:Colloidal bismuth citrate + amoxicillin + doxycycline + vonoprazan fumarate tablets;Research Group:Jinghua Weikang capsules + Amoxicillin + Doxycycline + Vonoprazan fumarate tablets |
| Registration date | Jan 17, 2026 |
| Target size | Control Group:45;Research Group:45 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: